Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway

Apoptosis

Volumn 11, Issue 6, 2006, Pages 943-953

  Chen, J ^a,b   Tang, X Q ^a,c   Zhi, J L ^a   Cui, Y ^a   Yu, H M ^a   Tang, E H ^a   Sun, S N ^a   Feng, J Q ^a   Chen, P X ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b CHINA THREE GORGES UNIVERSITY   (China)

^c Nahua University   (China)

Author keywords

Apoptosis; bcl 2; Curcumin; Cytoprotection; iNOS

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CURCUMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE POTENTIAL; CELL PROTECTION; CELL STRAIN; CELL VIABILITY; CYTOTOXICITY; DEGENERATIVE DISEASE; GENE OVEREXPRESSION; MITOCHONDRIAL MEMBRANE; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; CURCUMIN; ENZYME INHIBITORS; HERBICIDES; MITOCHONDRIA; NITRIC OXIDE SYNTHASE TYPE II; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES;

EID: 33745056543     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-6715-5     Document Type: Article

References (47)

1. Fahn S. Parkinsonism. In: Wyngaarden JB, Smith JR LH, ed. Cecil's Textbook of Medicine. Philadelphia, PA: Saunders 1988; 2143-2147.
2. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 1998; 13(Suppl 1): 24-34.
3. Jenner P, Olanow CW. Understanding cell death in Parkinson's disease. Ann Neurol 1998; 44(3 Suppl 1): S72-84.
4. Lyras L, Perry RH, Perry EK, et al. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J Neurochem 1998; 71(1): 302-312.
5. Zhang Y, Dawson VL, Dawson TM. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol Dis 2000; 7(4): 240-250.
6. Heales SJ, Bolanos JP, Stewart VC, Brookes PS, Land JM, Clark JB. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999; 1410(2): 215-228.
7. Qureshi GA, Baig S, Bednar I, Sodersten P, Forsberg G, Siden A. Increased cerebrospinal fluid concentration of nitrite in Parkinson's disease. Neuroreport 1995; 6(12): 1642-1644.
8. Hunot S, Boissiere F, Faucheux B, et al. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996; 72(2): 355-363.
9. Nadkarni KM. Indian material media. In: Nadkarni KM, ed. Bombay: Popular Prakashan 1976; 414-417.
10. Nurfina AN, Reksohadiprodjo MS, Timmerman H, Jenie UA, Sugiyanto D, Goot H van der. Synthesis of some symmetrical curcumin derivatives and their antiinflammatory activity. Eur J Med Chem. 1997; 32(4): 321-328.
11. Ramsewak RS, DeWitt DL, Nair MG. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 2000; 7(4): 303-308.
12. Mehta K, Pantazis P, McQueen T, Aggarwal BB. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 1997; 8(5): 470-481.
13. Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 1999; 147(2): 371-378.
14. Jaruga E, Bielak-Zmijewska A, Sikora E, et al. Glutathione-independent mechanism of apoptosis inhibition by curcumin in rat thymocytes. Biochem Pharmacol 1998; 56(8): 961-965.
15. Somasundaram S, Edmund NA, Moore DT, et al. Dietary Curcumin Inhibits Chemotherapy-induced Apoptosis in Models of Human Breast Cancer. Cancer Res 2002; 62: 3868-3875.
16. Chan WH, Wu CC, Yu JS. Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell Biochem 2003; 90(2): 327-338.
17. Przedborski S, Vila M. MPTP: A review of its mechanisms of neurotoxicity. Clin Neurosci Res 2001; 1: 407-418.
18. Sawada H, Ibi M, Kihara T, et al. Estradiol protects dopaminergic neurons in a MPP Parkinson's disease model. Neuropharmacology 2002; 42(8): 1056-1064.
19. Sheng GQ, Zhang JR, Pu XP, Ma J, Li CL. Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Eur J Pharmacol 2002; 451(2): 119-124.
20. Kostic V, Przedborski S, Flaster E, Sternic N. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson's disease. Neurology 1991; 41: 202-205.
21. Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004; 74(8): 969-985.
22. Ghoneim AI, Abdel-Naim AB, Khalifa AE, El-Denshary ES. Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain. Pharmacol Res 2002; 46(3): 273-279.
23. +-induced apoptosis. Eur J Neurosci 2003; 17(8): 1563-1570.
24. Rossetti ZL, Sotgiu A, Sharp DE, Hadjiconstantinou M, Neff NH. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro. Biochem Pharmacol. 1988; 37(23): 4573-4574.
25. Halasz AS, Palfi M, Tabi T, Magyar K, Szoko E. Altered nitric oxide production in mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydro-pyridin or methamphetamine. Neurochem Int 2004; 44(8): 641-646.
26. Vila M, Jackson-Lewis V, Vukosavic S, et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. Pro Natl Acad Sci USA 2001; 98: 2837-2842.
27. Jang JH, Surh YJ. Bcl-2 protects against Abeta(25-35)-induced oxidative PC12 cell death by potentiation of antioxidant capacity. Biochem Biophys Res Commun 2004; 320(3): 880-886.
28. Cadet JL, Harrington B, Ordonez S. Bcl-2 overexpression attenuates dopamine-induced apoptosis in an immortalized neural cell line by suppressing the production of reactive oxygen species. Synapse 2000; 35(3): 228-233.
29. Chen GG, Liang NC, Lee JF, et al. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway. Apoptosis 2004; 9(5): 619-627.
30. Yang L, Matthews RT, Schulz JB, et al. 1-Methyl-4-phenyl-1,2,3,6- tetrahydropyride Neurotoxicity Is Attenuated in Mice Overexpressing Bcl-2. J. Neurosci. 1998; 18: 8145-8152.
31. Offen D, Beart PM, Cheung NS, et al. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Proc Natl Acad Sci USA 1998; 95: 5789-5794.
32. Wu LY, Ding AS, Zhao T, Ma ZM, Wang FZ, Fan M. Involvement of increased stability of mitochondrial membrane potential and overexpression of Bcl-2 in enhanced anoxic tolerance induced by hypoxic preconditioning in cultured hypothalamic neurons. Brain Res 2004; 999(2): 149-154.
33. Yang J, Liu X, Bhalla K, et al. Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked. Science 1997; 275: 1129-1132.
34. Kane DJ, Sarafian TA, Anton R, et al. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science 1993; 262(5137): 1274-1277.
35. Bruce-Keller AJ, Begley JG, Fu W, et al. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J Neurochem 1998; 70(1): 31-39.
36. Deng G, Su JH, Ivins KJ, Houten BV, Cotman CW. Bcl-2 facilitates recovery from DNA damage after oxidative stress. Exp Neurol, Sep 1999; 159(1): 309-318.
37. Akao Y, Otsuki Y, Kataoka S, Ito Y, Tsujimoto Y. Multiple subcellular localization of bcl-2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes. Cancer Res. 1994; 54: 2468-2471.
38. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Pro Natl Acad Sci USA 1996; 93: 4565-4571.
39. Hantraye P, Brouillet E, Ferrante R, et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 1996; 2(9): 1017-1021.
40. Matthews RT, Yang L, Beal MF. S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity. Exp Neurol 1997; 143(2): 282-286.
41. Schulz JB, Matthews RT, Muqit MM, Browne SE, Beal MF. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. J Neurochem 1995; 64(2): 936-939.
42. Hantraye P, Brouillet E, Ferrante R, et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 1996; 2(9): 1017-1021.
43. Rao CV, Kawamori T, Hamid R, Reddy BS. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 1999; 20: 641-644.
44. Iravani MM, Kashefi K, Mander P, Rose S, Jenner P. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration. Neuroscience 2002; 110(1): 49-58.
45. Caivano M. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett 1998; 429(3): 249-253.
46. Cheng A, Chan SL, Milhavet O, Wang S, Mattson MP. p38 MAP Kinase Mediates Nitric Oxide-induced Apoptosis of Neural Progenitor Cells. J Biol Chem. 2001; 276: 43320-43327.
47. Chen GG, Liang NC, Lee JF, et al. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kappa B-related pathway. Apoptosis 2004; 9(5): 619-627.